In this context, Li et al. (2013) first analyzed both TP53 UTRs and showed that somatic alterations occurred frequently in these regions and that they had prognostic value in a large cohort of tumor specimens from patients with a subtype of lymphoma (Li et al., 2013). The gene discussed is TP53; the disease is neoplasm.